On the occasion of R2B 2025 – Research to Business, held at the Bologna exhibition center on June 25 and 26, the exhibition space dedicated to innovation hosted posters of research projects funded under the Emilia-Romagna Region’s specialization platforms. Among these was the N2ERT project, of which we are the lead partner, which gained visibility in a context of exchange between research, businesses, and the local area.
Next to the Main Stage, where important meetings were held, the “Tech Wall” offered visitors an overview of content, images, and keywords: an immersive journey in which each poster recounts the research trajectory, the technologies used, and the expected applications.
From an immersive experience to a look toward the future
N2ERT – Platform for the prototyping of nanomedicines for therapeutic proteins: enzyme replacement therapy for rare neurometabolic diseases
One of the main obstacles to ERT therapies for rare diseases of the central nervous system is the inability of therapeutic enzymes to cross the blood-brain barrier (BBB).
N2ERT addresses this challenge by developing innovative and easily reproducible nanodelivery systems capable of protecting enzyme activity and promoting targeted release into nerve tissue. This approach allows new formulations to be tested in preclinical models, evaluating their efficacy and safety to reduce the limitations of current therapies.
Looking ahead: synergies and next steps
For us, being present at R2B means not only communicating project updates, but also building new synergies with those who believe in innovation as a driver of collective well-being.
